Articles:

Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging

TL Chenevert, PE McKeever, and BD Ross
Clin Cancer Res 1997 3: 1457 [Abstract] [PDF]  

Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells

GK Schwartz, K Farsi, P Maslak, DP Kelsen, and D Spriggs
Clin Cancer Res 1997 3: 1467 [Abstract] [PDF]  

Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma

YX Hu, H Watanabe, K Ohtsubo, Y Yamaguchi, A Ha, T Okai, and N Sawabu
Clin Cancer Res 1997 3: 1473 [Abstract] [PDF]  

Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma

JH Carter, JA Deddens, JL Pullman, BM Colligan, LO Whiteley, and HW Carter
Clin Cancer Res 1997 3: 1479 [Abstract] [PDF]  

Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice

S Visonneau, A Cesano, MH Torosian, and D Santoli
Clin Cancer Res 1997 3: 1491 [Abstract] [PDF]  

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix

AP Kudelka, T Levy, CF Verschraegen, CL Edwards, S Piamsomboon, W Termrungruanglert, RS Freedman, AL Kaplan, DG Kieback, CA Meyers, KA Jaeckle, E Loyer, M Steger, R Mante, G Mavligit, A Killian, RA Tang, JU Gutterman, and JJ Kavanagh
Clin Cancer Res 1997 3: 1501 [Abstract] [PDF]  

Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy

PJ Foxall, JM Singer, JM Hartley, GH Neild, M Lapsley, JK Nicholson, and RL Souhami
Clin Cancer Res 1997 3: 1507 [Abstract] [PDF]  

Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial

SH Bernstein, JP Fay, NP Christiansen, L Pinero, D Shah, M Stephan, and GP Herzig
Clin Cancer Res 1997 3: 1519 [Abstract] [PDF]  

Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial

CM Kurbacher, HW Bruckner, IA Cree, JA Kurbacher, L Wilhelm, G Poch, D Indefrei, P Mallmann, and PE Andreotti
Clin Cancer Res 1997 3: 1527 [Abstract] [PDF]  

Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance

P Baille, R Bruno, JH Schellens, LK Webster, M Millward, J Verweij, and G Montay
Clin Cancer Res 1997 3: 1535 [Abstract] [PDF]  

Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy

V Gandhi, E Estey, M Du, MJ Keating, and W Plunkett
Clin Cancer Res 1997 3: 1539 [Abstract] [PDF]  

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial

DJ Macey, EJ Grant, L Kasi, MG Rosenblum, HZ Zhang, RL Katz, PT Rieger, D LeBherz, M South, JW Greiner, J Schlom, DA Podoloff, and JL Murray
Clin Cancer Res 1997 3: 1547 [Abstract] [PDF]  

Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients

SR Chinni, R Falchetto, C Gercel-Taylor, J Shabanowitz, DF Hunt, and DD Taylor
Clin Cancer Res 1997 3: 1557 [Abstract] [PDF]  

Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma

J Herrada, RB Iyer, EN Atkinson, N Sneige, AU Buzdar, and GN Hortobagyi
Clin Cancer Res 1997 3: 1565 [Abstract] [PDF]  

Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells

F Shapiro, TJ Yao, C Moskowitz, L Reich, DL Wuest, S Heimfeld, IK McNiece, J Gabrilove, S Nimer, and MA Moore
Clin Cancer Res 1997 3: 1571 [Abstract] [PDF]  

Angiogenic protein expression in advanced epithelial ovarian cancer

DP Barton, A Cai, K Wendt, M Young, A Gamero, and S De Cesare
Clin Cancer Res 1997 3: 1579 [Abstract] [PDF]  

Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms

Y Tagawa, T Yasutake, T Sawai, A Nanashima, M Jibiki, M Morinaga, F Akama, T Nakagoe, and H Ayabe
Clin Cancer Res 1997 3: 1587 [Abstract] [PDF]  

Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer

G Dalbagni, W Han, ZF Zhang, C Cordon-Cardo, P Saigo, WR Fair, H Herr, N Kim, and MA Moore
Clin Cancer Res 1997 3: 1593 [Abstract] [PDF]  

Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer

JM Hakimi, MP Schoenberg, RH Rondinelli, S Piantadosi, and ER Barrack
Clin Cancer Res 1997 3: 1599 [Abstract] [PDF]  

Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence

A Fortin, M Guerry, R Guerry, M Talbot, O Parise, G Schwaab, J Bosq, J Bourhis, P Salvatori, F Janot, and P Busson
Clin Cancer Res 1997 3: 1609 [Abstract] [PDF]  

Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer

BH Bochner, D Esrig, S Groshen, M Dickinson, N Weidner, PW Nichols, DG Skinner, and RJ Cote
Clin Cancer Res 1997 3: 1615 [Abstract] [PDF]  

High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases

AH Ree, VA Florenes, JP Berg, GM Maelandsmo, JM Nesland, and O Fodstad
Clin Cancer Res 1997 3: 1623 [Abstract] [PDF]  

Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis

FJ Xu, S Stack, C Boyer, K O'Briant, R Whitaker, GB Mills, YH Yu, and RC Bast, Jr
Clin Cancer Res 1997 3: 1629 [Abstract] [PDF]  

Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer

R Mazurchuk, D Glaves, and D Raghavan
Clin Cancer Res 1997 3: 1635 [Abstract] [PDF]  

Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer

JC Newby, SR Johnston, IE Smith, and M Dowsett
Clin Cancer Res 1997 3: 1643 [Abstract] [PDF]  

Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells

M Gupta, S Fan, Q Zhan, KW Kohn, PM O'Connor, and Y Pommier
Clin Cancer Res 1997 3: 1653 [Abstract] [PDF]  

Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma

BA Teicher, G Ara, D Buxton, J Leonard, and RG Schaub
Clin Cancer Res 1997 3: 1661 [Abstract] [PDF]  

Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations

KE McKenzie, A Siva, S Maier, IB Runnebaum, R Seshadri, and S Sukumar
Clin Cancer Res 1997 3: 1669 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.